---
title: "omacetaxine mepesuccinate - Chronic myeloid leukemia"
sidebar: mydoc_sidebar
permalink: omacetaxinemepesuccinatechronicmyeloidleukemia.html
toc: false 
---

{% include image.html file="omacetaxinemepesuccinatechronicmyeloidleukemia.png" alt="omacetaxinemepesuccinatechronicmyeloidleukemia" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C001652 | omacetaxine mepesuccinate | Drug |
| UniProt:P39023 | 60S ribosomal protein L3 | Protein |
| GO:0006412 | translation | BiologicalProcess |
| UniProt:A9UF02 | BCR/ABL protein-tyrosine kinase | Protein |
| MESH:D015464 | Chronic myeloid leukemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Omacetaxine Mepesuccinate | DECREASES ACTIVITY OF | 60S Ribosomal Protein L3 |
| 60S Ribosomal Protein L3 | PARTICIPATES IN | Translation |
| Translation | INCREASES ABUNDANCE OF | Bcr/Abl Protein-Tyrosine Kinase |
| Bcr/Abl Protein-Tyrosine Kinase | CAUSES | Chronic Myeloid Leukemia |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB04865#mechanism-of-action](https://go.drugbank.com/drugs/DB04865#mechanism-of-action){:target="_blank"}